Crane Co financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Crane Co files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	2,063	1,777	1,862	2,131	2,305
Cost of revenue	1,374	1,116	1,111	1,263	1,332
Gross profit	689	661	751	868	973
Research and development	49.5	48.3	54.8	46.1	47.8
Selling, general and administrative	467	494	501	512
Operating income	222	5.3	250	356	424
Interest expense	4.9	10.1	22.7	27.2	11.3
Interest income	1.3	3.2	5.1	5.5	11.2
Other non-operating income	12	231	-17.3	-17.3	8.6
Pre-tax income	234	237	233	339	433
Income tax	36.3	70.1	57.2	70.3	101
Income from continuing operations	197	166	176	268	332
Net income	435	401	256	295	367
EBITDA	260	39	286	407	474
EPS, basic	7.46	7.11	4.51	5.15	6.38
EPS, diluted	7.36	7.01	4.45	5.05	6.26
Shares, basic (weighted)	58.4	56.4	56.7	57.2	57.5
Shares, diluted (weighted)	59.2	57.2	57.5	58.3	58.6
Dividend per share	1.72	1.88	1.01	0.82	0.92

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents	377	427	330	307	507
Receivables		270	298	339	359
Inventory		294	344	380	377
Other current assets		135	100	159	106
Total current assets		1,752	1,091	1,403	2,571
Property, plant and equipment		248	245	261	279
Lease right-of-use assets		58.4	63.2	69.1	64.8
Goodwill	723	520	576	662	684
Intangible assets	77.3	70.7	87.1	160	150
Other non-current assets		121	133	145	166
Total assets		4,392	2,351	2,642	3,853
Accounts payable		179	157	188	190
Accrued liabilities		261	261	303	269
Deferred revenue		49.4	56.2	36.3	46
Short-term debt		400	0	0	0
Total current liabilities		1,488	467	543	465
Long-term debt		0	249	247	1,148
Lease liabilities		49.7	55.9	59.3	54.4
Other non-current liabilities		85.2	105	106	87.7
Total liabilities		2,488	973	1,001	1,790
Total debt		0	249	247	1,148
Paid-in capital		374	398	426	452
Retained earnings		2,823	961	1,218	1,532
Treasury stock		-864	0
Other comprehensive income		-503	-58	-61.9	20
Shareholders' equity		1,901	1,358	1,639	2,061
Minority interests		2.6	2.5	2.3	2.3
Total equity	1,835	1,904	1,360	1,641	2,063
Total liabilities and equity		4,392	2,351	2,642	3,853
Shares outstanding		56.3	56.9	57.3	57.6

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	435	401	256	295	367
Depreciation and amortization	38.4	33.7	35.4	51	50.2
Stock-based compensation	21.7	20.9	25.8	25.6	27.2
Deferred income tax	-4.9	-18.1	-18.7	-11.6	-2.1
Change in receivables	-36.5	-48.2	-23.7	-32.1	-13.4
Change in inventory	-27.4	-40.9	-42.1	-21.2	11.3
Change in payables	32.3	46.5	-1.9	23.8	2.9
Cash from operations	185	-499	162	258	395
Capital expenditures	-35.3	-33.3	-39	-36.6	-53.5
Acquisitions	0	0	-90.5	-201	-0.2
Purchases of investments	-10	0	0
Sales and maturities of investments	40	0	0
Cash from investing	18.2	288	-129	-230	-48.1
Debt issued	0	0	300	190	1,150
Debt repaid	-348	0	-451	-192	-248
Share buybacks	-96.3	-204	0
Dividends paid	-101	-106	-57.3	-46.9	-52.9
Cash from financing	-558	106	-423	-49.7	839
Exchange rate effect	-12.7	-39.4	3.6	-11.3	24
Net change in cash	-72.4	179	-328	-21.4	1,423
Free cash flow	150	-532	123	221	341
Interest paid	2.9	6.5	20.3	24.4	7.8
Income taxes paid	33.9	61	111	88.9	96.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $206.83 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	41.7%	Gross profit / revenue.
Operating margin	17.9%	Operating income / revenue.
EBITDA margin	21.0%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	17.1%	Pre-tax income / revenue.
Net margin	13.0%	Net income / revenue.
FCF margin	14.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.5%	Cash from operations / revenue.
Effective tax rate	24.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.3%	Net income / average total assets.
Return on invested capital (ROIC)	12.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	3.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	9.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	12.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	19.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	331.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	16.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	130.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	24.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-3.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	24.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-3.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	53.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	54.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	12.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-21.2%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	25.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	45.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	0.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.80x	Current assets / current liabilities.
Quick ratio	1.59x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.66x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.50x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	27.0%	Total debt / total assets.
Liabilities / assets	45.9%	Total liabilities / total assets.
Net debt	$736.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.35x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	12.9x	Operating income / interest expense.
Working capital	$951.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	49.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$185.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.64x	Revenue / average total assets.
Fixed asset turnover	6.88x	Revenue / average property, plant and equipment.
Inventory turnover	2.98x	Cost of revenue / average inventory.
Days inventory	123 days	365 x average inventory / cost of revenue.
Receivables turnover	5.31x	Revenue / average receivables.
Days sales outstanding	69 days	365 x average receivables / revenue.
Days payables	45 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	146 days	Days inventory + days sales outstanding - days payables.
FCF conversion	113.2%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	11.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.73	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$44.14	Revenue / diluted weighted shares.
FCF per share	$6.48	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.30	Cash from operations / diluted weighted shares.
Book value per share	$37.68	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.20	Tangible book value / shares outstanding.
Cash per share	$6.06	(Cash + short-term investments) / shares outstanding.
Payout ratio	16.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	14.7%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$11.95B	Share price x shares outstanding.
Enterprise value	$12.69B	Market cap + total debt - cash - short-term investments.
P/E	35.6x	Market cap / net income. Only when net income is positive.
P/S	4.61x	Market cap / revenue.
P/B	5.49x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	64.6x	Market cap / tangible book value, when positive.
P/FCF	31.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	27.9x	Market cap / cash from operations, when positive.
EV/Sales	4.90x	Enterprise value / revenue.
EV/EBIT	27.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	23.3x	Enterprise value / EBITDA, when both are positive.
EV/FCF	33.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.2%	Free cash flow / market cap.
Earnings yield	2.8%	Net income / market cap (the inverse of P/E).
Dividend yield	0.5%	Dividends paid over the period / market cap.
Shareholder yield	0.5%	(Dividends paid + share buybacks) / market cap.

What was Crane Co's revenue in fiscal 2025?

Crane Co reported revenue of $2.31B for fiscal 2025, 8.2% higher than the year before.

Was Crane Co profitable in fiscal 2025?

Yes. Net income was $366.6M, a net margin of 15.9%.

How much free cash flow did Crane Co generate in fiscal 2025?

Cash from operations of $394.8M minus capital expenditures of $53.5M left free cash flow of $341.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Crane Co